• Eloro Resources Ltd. Owns a 98% interest in Minera Tupiza with an option to acquire 99% interest in a neighboring highly sought after, royalty-free property in southern Bolivia
• Eloro has an option to acquire a 99% interest in the 9 square km, highly prospective Iska Iska Property, which hosts a major silver-tin polymetallic porphyry-epithermal complex located 4,000m above sea level

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a publicly traded exploration and mine development company, established in 1985 with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

Polymetallic Project in Bolivia

Bolivia’s modern mining laws and supportive political environment have made mining the largest contributor, at 30%, to the Bolivian economy. The country has a simple tax structure, no capital controls, 0% VAT on mining/industrial equipment, and uncomplicated mining laws.

Currently, Eloro owns a 98% interest in Minera Tupiza. with an option to acquire a 99% interest in the neighboring Iska Iska, a 9 square km silver-tin polymetallic property. Iska Iska is a highly sought after road-accessible, royalty-free property located near Minera Tupiza in the Potosi Department of southern Bolivia with easy access to seaports.

The exploration program is conducting 81,936 meters of diamond drilling and has four drill rigs on site. They have uncovered high metal values within an immense system. Mineralization has been encountered in every one of the 120 drill holes to date.

Eloro is committed to the well being of this historical mining region. The company has sponsored the local school and sports, is conducting environmental study and community discussions, and has hired a 100% Bolivian on-site team.

For more information, visit the company’s website at www.EloroResources.com.

NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

• Freight Technologies recently announced receipt of a two-year commitment from Kimberly Clark De Mexico, SAB de CV (“KCM”), that will significantly expand its Fr8PrivateFleet product
• Fr8Tech introduced Fr8PrivateFleet at the end of 2021 through its wholly owned subsidiary Freight App, Inc.capacity
• The product solves shippers’ need to secure freight over time rather than on a trip-by-trip basis and provides carriers, who can deliver the shipper’s loads based on this criterion, with a steady stream of employment opportunities and revenue
• The two-year commitment is set to more than triple Fr8Tech’s capacity in the Fr8PrivateFleet product over three months

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a company specializing in creating and providing supply chain optimization and automation solutions, and Freight App, Inc. (“Fr8App”), its wholly owned subsidiary, have always sought to create offerings that contribute to their clients’ success by improving efficiency and profitability. This operational principle is exemplified by, among others, the company’s technology solution for committed planning, Fr8PrivateFleet, which was launched late last year (https://ibn.fm/IuryE). Designed to help solve shippers’ needs to secure freight capacity over time rather than on a trip-by-trip basis and guarantee carriers a steady stream of revenue, Fr8PrivateFleet matches carriers who have the capacity to carry a predetermined amount of load over a stated period, with shippers. To take advantage of the convenience offered, shippers pay for the capacity they require, while the carriers commit to using Fr8Tech’s B2B marketplace, known as Fr8App, to operate all of their loads and track the progress of their loads.  Active tracking of the loads and their progress helps improve security for all parties. The advantages of Fr8PrivateFleet persuaded new and existing Fr8App customers to integrate it into their operations, among them the product’s first client, Kimberly Clark de Mexico, SAB de C.V. (“KCM”), and one of Mexico’s largest food producers (https://ibn.fm/hUYKs). Over the months since Fr8Tech announced KCM as Fr8PrivateFleet’s first client in February this year, the relationship has expanded significantly. For instance, in September, Fr8Tech announced it would support other logistics services for KCM in addition to offering the committed capacity planning product. These include dedicated truck service on the Fr8App platform, traditional spot services within domestic Mexico, and cross-border logistics for shipments from Mexico to the United States and Canada (https://ibn.fm/qarKR). In a development that further expands this relationship, Fr8Tech recently announced it had secured a two-year commitment from KCM to expand its fleet product. The commitment, once fulfilled, is estimated to triple Fr8Tech’s capacity in its Fr8PrivateFleet solution over the next three months, according to an October 27 news release (https://ibn.fm/6F1Yd). “It is very rewarding to receive this commitment, which we will begin to fulfill as soon as we secure the capacity required to do so,” commented Luisa Lopez, COO of Fr8App. “An attractive feature of a longer-term contract is that it secures a stream of steady business on our Fr8App platform over the term of the contract. As a company, we have invested a significant amount of time and resources in developing the Fr8PrivateFleet product, and it is very encouraging to receive a commitment of this size from such an important company in this segment.” Having dedicated time and money over the past year to expand its domestic freight and traffic offerings in both Mexico and the United States, Fr8Tech CEO Javier Selgas notes, the company “trusts that this is the first in a number of new agreements that we will secure over the coming months in relation to our Mexico domestic market offerings. We are only beginning to see a return on this important investment by our company and its investors.” For more information, visit the company’s website at www.Fr8Technologies.com. NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT Corporate Communications IBN (InvestorBrandNetwork) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

• Solar is blooming; from 2020 to 2021, residential solar power grew by 34%
• In 2022, Americans are increasingly going solar for environmental, health and financial reasons: 8% of US surveyed homeowners have installed solar panels – up from 6% in 2019 and 4% in 2016
• GeoSolar is poised to capitalize on this growth potential with its SmartGreen(TM) Home system that helps American homeowners tackle both environmental and financial issues at once

In a world unsettled by rising fuel costs and heightened energy uncertainty, solar emerges as part of a potential solution. Consequently, the sector is booming, transforming from a niche investment driven by ecological rather than monetary factors into a new mainstream investment opportunity that seeks to achieve both environmental and economic goals. As a company offering technology designed to harness energy from the earth and sun to power homes without the use of fossil fuels, GeoSolar Technologies (“GST”) appears well-positioned at the front of what may look like an eco-friendly revolution spurring more and more Americans to go solar. Although residential solar power currently accounts for only a fraction of the total US electricity, the sector has continued to snowball over recent years. This includes a period of considerable disruption due to obstacles such as COVID-19-related supply chain challenges and import restrictions. From 2020 to 2021 only, residential solar power grew from 2.9 gigawatts to 3.9-gigawatt installations, which makes a 34% growth rate (https://ibn.fm/Tusig). With new legislation that enables larger investments in renewable energy and measures to address climate change, including a 30% solar tax credit, the industry is expected to accelerate its growth. A Pew Research Center survey conducted in January, before the announcement of federal tax incentives, reports that 8% of surveyed homeowners have already installed solar panels – a significant growth from 6% in a 2019 and 4% in 2016. In addition, 39% have given serious consideration to this possibility over the past year. Most homeowners said helping the environment and improving health were their motivations for installing solar panels or considering doing so, while financial incentives also played a part. But there is a long road ahead of solar, particularly for the residential segment of the sector. According to the U.S. Energy Information Administration (“EIA”), around 3.7% of U.S. single-family homes generated electricity from small-scale solar arrays in 2020 (https://ibn.fm/NfLiU). Compared to large utility-scale solar, which includes facilities such as solar panel farms, residential solar still generates less electricity-and all solar power together generates only a small fraction of the electricity consumed in the US. For example, last year, solar generated just 3% of all utility-scale electricity, dwarfed by natural gas (38%) or coal (22%) (https://ibn.fm/6dvof). Notwithstanding its small size, solar adoption in all sectors, from residential to the utility-scale, is expected to explode over the next decade. By 2024 only, the capacity added is expected to rise to a level five times bigger than what was observed in 2020. Due to its rapid growth, the sector attracts increasing attention from investors. It is estimated that investment in solar could reach $321 billion in 2030, which is almost double the figure of $177 billion expected under current policy, leading to nearly $3.5 trillion in cumulative capital investment in new American energy supply over the next ten years. As a readily available and renewable energy source, solar could become one of the lowest-cost energy options in the years to come. Confident that the world is in the early stages of what might be one of the most consequential transitions in human history — the shift from a fossil fuel-driven present to a clean all-electric future — GeoSolar seeks to lead Americans toward a greener future. Its SmartGreen(TM) Home system, designed for newly built and existing residences, offers homeowners zero or no utility bills and a healthier carbon-free living environment. With inflation soaring to the highest levels in decades and the threat of climate crisis becoming increasingly palpable, GeoSolar seeks to offer American homeowners solutions that help them save money and help the planet all at once. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• Lexaria’s HYPER-H21-4 human clinical study was a success, producing favorable results in treating hypertension when comparing the company’s patented DehydraTECH(TM) CBD with a placebo
• According to a Zacks SCR report, the findings support their $15 share valuation of the company
• Zacks expects Lexaria to penetrate global markets for hypertension, nicotine delivery and antiviral products
• The hypertension drug market is expected to grow to over $34 billion through 2030, with North America anticipated to hold 35% of the market share

According to the World Health Organization (“WHO”), approximately 1.13 billion people worldwide suffer from hypertension (high blood pressure), with only one in five being treated or under control. The hypertension drug market size in 2021 was valued at $25,394 million and is expected to grow at a CAGR of 3.4% through 2030, resulting in an estimated value of $34,072 million. The North American market is expected to lead with more than 35% of the world market share (https://ibn.fm/QQ33h). Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently released impressive results from its fourth and most comprehensive hypertension study, HYPER-H21-4. The study, structured as a randomized, double-blind, placebo-controlled cross-over study, dosed 66 male and female volunteers between the ages of 40-70 with stage 1 or 2 hypertension, comparing the company’s patented DehydraTECH(TM) cannabidiol (“CBD”) against a placebo. The study showed patients receiving placebo doses trended toward increases in blood pressure (“BP”) during the period of the study compared to baseline, while the average BP measured by each of mean arterial BP, systolic BP and diastolic BP significantly decreased from baseline when dosed with DehydraTECH-CBD; and those decreases were maintained during the full 5 weeks of dosing  – with no serious adverse events or hepatic changes occurring (https://ibn.fm/38KF3). Lexaria’s DehydraTECH technology is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients, increasing effectiveness and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream. In 2021, animal studies demonstrated that DehydraTECH elevated drug quantities across the blood-brain barrier by as much as 1,700%, which initiated further investigations  and opened the possibilities for improved drug delivery. The benefits of using Lexaria’s patented technology include the following:

• Improves the speed of onset, with effects felt in minutes
• Increases bioavailability by more effectively delivering the drug into the bloodstream
• Increases brain absorption, with testing suggesting up to 10x improvement
• Reduces drug administration costs with a higher ratio of drug delivery

Lexaria announced the enrollment for HYPER-H21-4 in an April 19 press release, and dosing began ahead of schedule, with completion on July 27, with no serious adverse events reported as a result of the dosing. The maximum dose levels in the study were roughly 5 mg/kg/day, which is significantly lower than maximum dose levels practiced for other regulator-approved pharmaceutical CBD applications., The company will use data from the study to support its Investigational New Drug (“IND”) application with the FDA. According to a Zacks Small-Cap Research (“Zacks SCR”) report, the company’s next steps for the hypertension program will be to submit and receive clearance for an IND application, and the application and IND clearance will support the start of the Phase Ib study slated for 2023 (https://ibn.fm/L7LRB). Longer term goals for the program are to find a partner who will advance the work to a registrational study and send it to the FDA for approval. While this is several years away, the data that has been released so far is supportive of further development. Zacks SCR forecasts penetration by Lexaria into global markets for hypertension, nicotine delivery, and antiviral product categories. The Zacks SCR valuation of $15 per share assumes a 2024 regulatory approval and commercialization of DehydraTECH CBD in the United States and developed markets – a valuation maintained throughout the report. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• While economies worldwide are struggling to control spiking inflation rates, REZYFi, a mortgage lender servicing non-traditional as well as other loans, sees unique financial opportunities
• Through the use of proprietary automated machine learning and associated technologies, together with preparations to launch a high-margin cannabis division later this year to serve an industry in need of loan origination options, REZYFi is working to grow its operation
• RZFI is licensed in more than 30 U.S. states and expects to expand its loan origination services to all remaining states in coming months

Economic challenges resulting from governmental efforts to tame inflation could in turn create new opportunities for hard-to-finance sector lenders, especially as mortgage rates eventually fall as recently suggested by CNN Business (https://ibn.fm/EBSYB). The fight against inflation has delivered successes in the United States — what investment bank Goldman Sachs refers to as “remarkable” progress in slowing the US economy and easing the concerning imbalance between supply and demand in the jobs market, though Goldman also warns against going too far in the inflation battle. “Fiscal and monetary policy tightening has so far managed to slow demand growth sharply without accidentally overdoing it and sparking a recession, an impressive achievement,” Goldman Sachs economists stated in a recent note to their clients (https://ibn.fm/7HK1I). Specialized financing company REZYFi is pursuing a growth strategy cognizant of the economic pressures, preparing to launch a high-margin cannabis division later this year while managing staffing levels and applying proprietary technologies for efficiency. The cannabis industry has historically struggled with obtaining loans and other bank services because of the U.S. government’s continued regulation of the leafy green plant as a highly controlled substance. State governments have created legalized avenues for the cannabis market in recent years, but the industry continues to hope for better financing conditions, such as those proposed under the Secure and Fair Enforcement (“SAFE”) Banking Act and the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act that have cleared the House of Representatives and are awaiting a decision from the Senate. The measures would prevent federal regulators from penalizing banks that serve the cannabis industry or decriminalize cannabis outright (https://ibn.fm/C25wP). For REZYFi, all of this has created a significant window of opportunity, of which the company has taken advantage. As a result, the company is now licensed in more than 30 U.S. states, with expectations to expand its loan origination and services to all remaining states. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• Climate change and industrialized pollution emissions continue to raise warnings worldwide that the quality of human life is being compromised
• U.S.-based Correlate Infrastructure Partners is working to establish solutions for its clients by assessing utilities inefficiencies, advising on affordable improvements, and then helping to successfully implement changes through access to highly cost-effective financing opportunities
• The federal government’s recent passage of greenhouse gas reduction financing opportunities through the Inflation Reduction Act (“IRA”) has established the government as a ready partner in companies’ ESG policies
• The IRA has become particularly attractive to public, non-profit, and REIT entities because of changes to subsidy availability
• A low increase in global carbon dioxide emissions associated with energy use this year shows that industries are finding increased motivation to improve their greenhouse gas profiles

Progressive tech hub Seattle, where Amazon and Microsoft are headquartered, made headlines last month for an age-old problem — pollution, when Seattle, helped by wildfires, was briefly classified as the worst city worldwide for air quality and pollution, and was kept among the planet’s top polluters for a while even after it fell out of the top spot (https://ibn.fm/rploW). While wildfires and unusually hot, dry climate conditions were blamed for the spike in poor air quality (https://ibn.fm/LIRap), more than a third of the city’s persistent greenhouse pollutants are attributed to climate-unfriendly energy use by residential, commercial and industrial buildings. Efforts to curb the building pollution, not just in Seattle but across the Washington state, has led Washington’s Building Code Council to require heat pump installation in large and commercial buildings by July in a bid to increasingly electrify utilities and move away from carbon-based fuels (https://ibn.fm/9bgta). Clean energy solutions innovator Correlate Infrastructure Partners (OTCQB: CIPI) is committed to facilitating improvements in greenhouse gas reduction through correlated efforts by its subsidiaries to advise the commercial real estate industry (companies that develop and rent out commercial building properties) on opportunities to change their carbon pollutant output and then help them implement those changes with available financing solutions. The Inflation Reduction Act (“IRA”) recently passed by the Biden administration is credited for opening up financing for a large number of pollution-reducing, climate-positive efforts through energy-related tax credits. Subsidies for energy efficiency retrofits and renewable energy installations are expected to be particularly useful for tax-exempt public and non-profit entities as well as real estate investment trusts (“REITs”) because those entities have thus far been unable to find financial incentive to improve their ESG profiles because they don’t have taxable income for decarbonization tax credits to offset. “We can now take 20-30% off the top of capital projects that we would typically need to pass on. Reducing that up front cost opens up a new playbook,” the vice president of REIT Macerich’s Corporate Responsibility and Sustainability division told smart building tech community Nexus Pro last month (https://ibn.fm/QGc8f). Some climate activists have gone so far as to encourage the president to use “the full powers of the federal government” to require huge cuts to building emissions nationwide (https://ibn.fm/eJahH) but Correlate Infrastructure Partners is optimistic that the trend toward increasing ESG investment by the younger generation (https://ibn.fm/YHSVQ) is helping to motivate companies to  clean their own houses. An Oct. 20 report by Scientific American noted that global carbon dioxide emissions associated with energy use are on track to increase 1 percent this year but added that the 1 percent increase is “significantly less than what many observers projected earlier this year” and a landmark step in creating continued climate change solutions (https://ibn.fm/XjgSP). For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• The CCPA limits data flows to brands and marketers, and CPRA amendments are set to take effect January 1, 2023
• CPRA and CCPA provisions include the right to opt-out of data sharing and sale, as well as the right to data deletion
• Consumer data is critical to branding and advertising strategies
• Reklaim provides an ecosystem that equips marketers with fully compliant, consumer-verified data sets while rewarding consumers for sharing information

With the aim of protecting consumers, the California Consumer Privacy Act (“CCPA”) and amendments provided by the California Privacy Rights Act (“CPRA”) are gradually transforming the advertising landscape by limiting data flows to brands and advertisers. Reklaim (TSX.V: MYID) (OTCQB: MYIDF) is firmly positioned to fill the void with a privacy-compliant desktop and mobile identity ecosystem that provides relevant datasets to marketers while rewarding consumers for sharing their data. Data fuels the company’s need to market activities for brands and advertisers. However, options are gradually decreasing due to privacy laws restricting information flow of information to the market. One such law is the CCPA, which took effect on January 1, 2020, and is set to be amended by the CPRA on January 1, 2023 (https://ibn.fm/UbGB0). The CCPA’s initial provisions give consumers the right to know what data is collected, why it is collected, if it is sold and what party bought the information. They also offered the right to delete this data. The CPRA adds two additional provisions: the right to correct inaccurate personal information and the right to limit the use and disclosure of sensitive personal data. The CCPA and subsequent CPRA amendments impose these obligations on businesses, service providers, contractors and third parties. Consequences for non-compliance include penalties of up to $7,500 per intentional violation, $2,500 per unintentional violation and statutory damages of up to $750 per consumer per incident. California is the world’s sixth-largest economy, ahead of Italy and closely behind France (https://ibn.fm/nzX82), making it a highly lucrative jurisdiction for brands and advertisers. In addition to severely limiting marketing activities in the United States, similar laws enacted in other countries threaten to greatly reduce the impact of advertising campaigns worldwide (https://ibn.fm/QLTnl). Reklaim is strongly positioned to support brands with fully consensual, consumer-verified data through an ecosystem that rewards users for sharing their data while providing verified datasets advertisers can access for a fee. Besides being fully compliant, Reklaim’s platform offers more relevant and higher-quality data, because consumers on the platform actively provide and choose to share their information. According to Fortune Business Insights, the global customer data platform market was valued at $1.42 billion in 2022 and is expected to reach $6.94 billion by 2029, expanding at a CAGR of 25.4% over the forecast period (https://ibn.fm/ZCUUC). As demand for consumer data continues to rise amid legislative restrictions, Reklaim provides valuable, transparent and high-quality solutions that benefit both sides of the consumer data market. For more information, visit the company’s website at www.ReklaimYours.com. NOTE TO INVESTORS: The latest news and updates relating to MYIDF are available in the company’s newsroom at https://ibn.fm/MYIDF

• CNS Pharmaceuticals is focused on advancing its clinical development for the Berubicin drug candidate in order to bring meaningful treatment to GBM patients
• GBM, which has a low survival rate, has limited treatment options when it progresses after first-line therapy
• The company is looking to find a solution with Berubicin and is currently evaluating this drug candidate in a potentially pivotal global study
• CNS’s ongoing R&D efforts are boosted by its strong cash position; in its Q2 2022 report, the company announced it had cash of about $9.0 million and working capital of $10.5 million

CNS Pharmaceuticals (NASDAQ: CNSP), an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system (“CNS”) cancer, started 2022 on a high, closing an $11.5 million private placement whose net proceeds the company intended to deploy toward funding its clinical trials and preclinical programs as well as other research and development (“R&D”) activities and general corporate purposes. The additional funding not only boosted the company’s R&D efforts but also enhanced its cash position, as reflected in its subsequent financial reports (https://ibn.fm/GK93f). In its report for the three months ended June 30, 2022 (“Q2 2022”), CNS Pharmaceuticals had cash and cash equivalents of about $9.0 million and working capital of $10.5 million (https://ibn.fm/UiG9a). And although the figure represented a drop from about $12.4 million and $13.7 million, respectively, recorded in the period ended March 31, 2022 (“Q1 2022”) (https://ibn.fm/ycZXd), the company spent 46% more on R&D in Q2 2022 than in Q1 2022. (Its R&D expenditure in Q2 2022 was $2.2 million.) CNS Pharmaceuticals expects its cash on hand and proceeds from the placement to fund its operations into Q1 2023. The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for Glioblastoma Multiforme (“GBM”), according to CNS Pharmaceuticals CEO John Climaco. The company’s focus and priorities, Climaco emphasized, are firmly anchored in the advancement of its clinical development for its drug candidate Berubicin with the aim of bringing meaningful treatment to GBM patients. And as he separately told attendees at the recently held H.C. Wainwright 24th Annual Global Investment Conference, this focus is driven by a significant unmet clinical need, especially given that recurrent GBM does not have “an approved therapy anywhere in the world” (https://ibn.fm/ciFue). For GBM patients, this unmet need causes anguish that often culminates in death. A 2021 study, for instance, notes, “Once tumors progress after first-line therapy, treatment options are limited, and the management of recurrent GBM remains a challenge” (https://ibn.fm/4ZfEE). Another, a 2015 study, underlines that recurrence is, unfortunately, inevitable, with its management unclear and case-dependent (https://ibn.fm/DRKYF). These characteristics have meant that GBM remains one of the most aggressive primary brain tumors, with a grim prognosis. Data from the American Cancer Organization shows that GBM has the least 5-year relative survival rate of the various common adult brain and spinal cord tumors in the list. For example, among 20- to 44-year-old patients, the survival rate stands at 22%. This figure drops to 9% among adults aged between 45 and 54 and 6% among those between 55 and 64. In comparison, anaplastic astrocytoma, the condition with the second lowest survival rate in the list, has higher survival rates of 58%, 29%, and 15%, respectively, across the three age categories (https://ibn.fm/IR0ko). The condition’s aggressiveness is further concretized by the fact that over 10,000 patients succumb to GBM annually in the United States, where 13,000 people are diagnosed with GBM every year the average length of survival for GBM patients is estimated to be only eight months. (https://ibn.fm/hUVew). With the survival rate and mortality statistics for GBM remaining virtually unchanged for decades, according to the National Brain Tumor Society, CNS Pharmaceuticals is working hard to find a solution. The company is relying on Berubicin, a novel anthracycline whose mechanism of action is inhibiting the topoisomerase II enzyme that causes cell replication and is abundantly found in tumor cells. CNS Pharmaceuticals has observed that the drug, which appears, based on limited clinical data, to cross the blood-brain barrier, is selectively absorbed in cancerous cells and tissue in the brain. The Berubicin drug candidate solves a problem that has long dogged cancer research for years. Although anthracyclines have existed for the past six decades, they could not cross the blood-brain barrier. CNS Pharmaceutical’s drug candidate, therefore, is the first anthracycline to appear to cross this critical barrier. The company is currently undertaking a potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent GBM. For more information, visit the company’s website at www.CNSPharma.com. NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

• The upcoming COP27 Conference in Egypt will dictate the world’s latest measures designed to adhere to 2015’s Paris Agreement
• With the world increasingly focused on containing global warming and subduing household greenhouse gas emissions, has taken on increasing relevance
• Within the U.S., households account for 20% of total carbon emissions – with U.S. household emissions alone surpassing those of Germany as a whole
• GeoSolar Technologies’ revolutionary SmartGreen(TM) Home system has been designed to power homes through a mix of renewable energy sources – effectively reducing the average home’s carbon footprint to near zero

When the upcoming United Nation’s Climate Change Conference, better known as ‘COP27’, kicks off in Egypt’s Sharm El-Sheikh on November 6th, it will do so amidst some of the most perilous environmental conditions the world has ever witnessed. Faced with a growing energy crisis, record greenhouse gas concentrations, and increasing extreme weather events, politicians will be at pains to deliver action on an array of issues critical to tackling the ongoing climate emergency. Ranging from urgently reducing greenhouse gas emissions, through to building resilience and adapting to the inevitable impacts of climate change, all whilst delivering on commitments to finance climate action in developing countries, conference attendees will be asked to commit to a wide array of initiatives to halt global warming on its tracks. With 40 percent of greenhouse gas (“GHG”) emissions originating from real estate, measures to decarbonize households will form an increasing priority within the global political agenda – with tackling US household emissions foremost on that list (https://ibn.fm/8bSbt). A comprehensive study encompassing 93 million individual households within the United States found that residential energy usage accounts for as much as 20 percent of GHG emissions in the United States (https://ibn.fm/A7ydM). Putting that figure into perspective – if the U.S. housing sector’s emissions were to be considered as a country, that country would represent the world’s sixth largest GHG emitter, comparable to the entirety of Brazil’s emissions and ranking significantly higher than those of Germany. Perhaps more ominously, by 2025 the United States will add an estimated 70-129 million residents and 62-105 million new homes, growing the urgent need to reduce emissions across the US housing sector. Consequently, and despite U.S. homes becoming increasingly energy efficient in recent years, U.S. household energy use and consequently, the sector’s GHG emissions, have failed to reduce as a by-product of demographic trends, necessitating the employment of additional measures to arrest the incessant growth in carbon dioxide emissions. GeoSolar Technologies (“GST”), a Colorado-based climate technology company, has sought to cater to this increasingly urgent requirement. Through the introduction of its proprietary SmartGreen(TM) Home system – an environmentally friendly, renewable energy focused technology designed to harness energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels, GeoSolar are focused to tackle the astounding thirty percent of global greenhouse gases generated by households every year. Moreover, and during a time of increasingly elevated electricity costs, the company has illustrated how the average GeoSolar-powered home could result in a negligible carbon footprint, with homeowners disbursing less than $100 per annum in utility bills (https://ibn.fm/QBDD9). Solar, wind, and hydroelectric power have long been renowned as popular and well accepted renewable energy sources, with a number of these achieving grid cost parity relative to more conventional energy sources in different jurisdictions. Whilst GeoSolar have made use of a variety of conventional forms of renewable energy within its home energy systems, it has also looked towards adopting a more holistic approach by harnessing other, more unconventional energy sources, including the likes of geothermal energy; effectively, tapping into heat generated from the Earth’s core to generate electricity (https://ibn.fm/jRt9R). The geothermal energy is than used to power heat pumps, with the latter employed to warm houses rather than having households rely on more conventional air-conditioning and gas furnace systems. With the world’s climate increasingly seen to be teetering on a precipice, global coordinated action will be essential in terms of preserving the environment as we see it today. Given the important role controlling household emission levels will play within this initiative, GeoSolar Technologies’ revolutionary SmartGreen(TM) Home system as well as its innovative use of renewable energy sources could not have come at a better time. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• The United States is still the world’s largest economy and largest importer and exporter of goods and services – with strong ties to Mexico and Canada
• Mexico has reached number one as a US trade partner, with a value of $520.12 billion during the first eight months of 2022, followed by Canada
• Freight Technologies’ cloud-based marketplace, Fr8App, is simplifying Over-The-Road (“OTR”) trade and reducing the carbon footprint in the industry by directly matching OTR shippers with qualified carriers and provides 24/7 live tracking, quick pay, and driver rating features
• The company is building strategic relationships with key customers across trade industries, expanding its customer base to provide its all-in-one solution for shippers with more reliable results and lower costs

Trade is vital to America’s prosperity as the world’s largest economy and largest importer and exporter of goods and services. Trade fuels economic growth, supports good jobs, raises living standards, and helps provide families with affordable goods and services. For the first time since January of this year, Mexico overtook Canada as the number one trade partner of the United States in August, increasing trade to $520.12 billion through the first eight months of the year, according to Census Bureau data analyzed by World City (https://ibn.fm/2YU7w). The most popular point for commercial truck crossings between the United States and Mexico is Laredo, Texas, which saw an increase of 12.8%, equivalent to 246,019 vehicles during August – ranking the port number two among the 450 ports, seaports, and border crossings between the United States and Mexico. The increase has brought the total number of truck crossings in Laredo to 2.7 million, an increase of 8.9% year to date. Some of the biggest challenges experienced by freight carriers since the COVID-19 pandemic include global supply chain disruptions, increased ocean freight rates, and logistics challenges – but demand for importing and exporting is as strong as ever. Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process and provides a platform for B2B cross-border shipping across the USMCA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international OTR shipping. Fr8Tech is leveraging its technology to help improve their customers’ operational efficiency and security while reducing its carbon footprint by optimizing empty miles and reducing paper consumption. Fr8App is a cloud-based marketplace that combines all aspects of a centralized control center into one platform – directly matching cross-border shippers throughout Mexico, Canada, and the United States with available carriers and drivers for their loads and capable of tracking status from start to finish. Powered by artificial intelligence and machine learning, Fr8App is the company’s B2B marketplace offering a real-time portal to connect shippers with qualified carriers. The Fr8App comes with 24/7 live tracking, quick pay, and driver ratings to make the process faster, more secure, and at the best pricing possible. The commercial trucking market is full of inefficiencies that create problems for both shippers and carriers equally, including a lack of transparency in pricing, inefficient matching, low technological penetration, and complexity of cross-border trades – Fr8App automates the process, making it more efficient and reducing logistic costs while improving security. The company is building strategic relationships with key players in the transportation industry, allowing faster growth of its customer base with enterprise accounts. With major imports and exports stemming from technology and other goods and services, the integration of these companies is allowing for Fr8Tech to provide an all-in-one solution for the inefficiencies these customers face in the transportation industry today by connecting the US, Mexico, and Canadian Marketplace (“USMCA”) with a single shipping solution. For more information, visit the company’s website at www.Fr8Technologies.com. NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT Corporate Communications IBN (InvestorBrandNetwork) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com